IHH Annual Report 2024

49 Five Strategic Priorities Grow Organically Capture Inorganic Opportunities Expand across Healthcare Continuum Turnaround Underperforming Assets Develop New Growth Engines Link to Strategic Priorities Our Response IHH is actively addressing potential policy and cost impacts through operational efficiencies and strategic resource allocation. We are mitigating energy volatility via renewable initiatives, including solar panel deployment across Malaysian hospitals by 2025 and investing in a solar farm in Türkiye. To manage currency risks in Türkiye, we’ve diversified and added foreign currency revenue streams. We remain committed to transparent investor communication, emphasising our diversified portfolio, strong market positions and proactive risk management. These strategies ensure our resilience and ability to deliver long-term shareholder value in challenging economic conditions. IHH recognises this trend as a strategic opportunity. We are proactively adapting by expanding bed capacity, investing in cutting-edge medical technologies, expanding our specialised service offerings, and strengthening our operational efficiencies. We also focus on developing innovative solutions to manage rising healthcare costs, ensuring accessibility and value for our patients. Our disciplined approach to capital allocation and our commitment to delivering high-quality, value-based care, exemplified by our Value-Driven Outcomes (VDO) initiatives, position us to capitalise on this growing demand while maintaining sustainable financial performance. We will also continue to attract and retain our healthcare professionals to support this growth. IHH recognises technological innovation as a key driver of sustainable growth and enhanced shareholder value. We are strategically investing in digital health solutions and AI-powered analytics to improve patient experience, enhance clinical decision-making, and streamline operational workflows. IHH is committed to adopting advanced medical technologies to improve patient outcomes. Our MyHealth360 app empowers patients in Malaysia and Singapore with comprehensive health management. We have also deployed virtual consultations and AI-powered bill estimates. We have clear, measurable ESG goals – set since 2022 – and track our performance year on year. Our increasing use of solar energy also puts us on track towards carbon neutrality. As recognition for our efforts, in December 2024, we were included in the FTSE4Good Bursa Malaysia index as well as the FTSE4Good Bursa Malaysia Shariah index. Additionally, our annual antimicrobial resistance (AMR) campaign aims to increase the awareness of this ‘hidden pandemic’ among the public, healthcare workers and policymakers so as to reduce healthcare burden. More details found in our Sustainability Report.

RkJQdWJsaXNoZXIy NDgzMzc=